The Rundown AI·
PLUS: Use Codex to build a functional game in one prompt
Read full articleThe closest the field has come to solving the planar unit distance problem, first proposed in the 1940s, was in 1984. Now, OpenAI claims an internal model has cracked the puzzle.
The model helps enterprises with complex workflows and lets them choose a mode that works for their application.
When newly public companies have been valued as richly as SpaceX, OpenAI and Anthropic seem likely to be, the outlook for ordinary investors has been poor.
Pope Leo XIV may not be able to disarm AI, but he’s got the attention of the industry.
Anthropic is set to tap a $36 billion private credit deal led by Blackstone and Apollo to finance Google AI chips backed by Broadcom, in one of history’s largest debt financings. Private equity giants Apollo Global Management and Blackstone are…
The post OpenAI biodefense program targets pandemic preparedness appeared on BitcoinEthereumNews.com. A new OpenAI biodefense program is pushing the company deeper into one of AI’s most sensitive frontiers: pandemic preparedness. The move is not just about building models. It combines startup investing, policy engagement, and safety systems aimed at spotting biological threats before they turn into wider crises. That strategy has been taking shape for months. In July 2025, OpenAI brought together government entities, NGOs, and researchers for a biodefense summit focused on countermeasures and dual-use risks. Then, within weeks later that year, it backed two startups working on biological risk detection and mitigation. The pattern matters because it shows OpenAI treating biosecurity less like a side research topic and more like an emerging operating priority. At a time when AI’s role in life sciences is expanding fast, the company appears to be building a position that spans tools, part
The artificial intelligence giant was just valued at $900 billion, surpassing OpenAI. Here are the numbers behind its rise — and headwinds it faces.
Boston Children’s Hospital uses OpenAI technology to improve patient care, reduce operational burden, and help diagnose more than 40 rare disease cases.
